SG11201502089QA - Methods of diagnosing liver cancer in a subject and a kit for diagnosing liver cancer - Google Patents

Methods of diagnosing liver cancer in a subject and a kit for diagnosing liver cancer

Info

Publication number
SG11201502089QA
SG11201502089QA SG11201502089QA SG11201502089QA SG11201502089QA SG 11201502089Q A SG11201502089Q A SG 11201502089QA SG 11201502089Q A SG11201502089Q A SG 11201502089QA SG 11201502089Q A SG11201502089Q A SG 11201502089QA SG 11201502089Q A SG11201502089Q A SG 11201502089QA
Authority
SG
Singapore
Prior art keywords
liver cancer
diagnosing liver
kit
subject
methods
Prior art date
Application number
SG11201502089QA
Inventor
Kam Man Hui
Original Assignee
Singapore Health Serv Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Singapore Health Serv Pte Ltd filed Critical Singapore Health Serv Pte Ltd
Publication of SG11201502089QA publication Critical patent/SG11201502089QA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SG11201502089QA 2012-09-21 2013-09-23 Methods of diagnosing liver cancer in a subject and a kit for diagnosing liver cancer SG11201502089QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261704425P 2012-09-21 2012-09-21
PCT/SG2013/000414 WO2014046623A1 (en) 2012-09-21 2013-09-23 Methods of diagnosing liver cancer in a subject and a kit for diagnosing liver cancer

Publications (1)

Publication Number Publication Date
SG11201502089QA true SG11201502089QA (en) 2015-06-29

Family

ID=50341782

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201502089QA SG11201502089QA (en) 2012-09-21 2013-09-23 Methods of diagnosing liver cancer in a subject and a kit for diagnosing liver cancer

Country Status (7)

Country Link
US (1) US20150232943A1 (en)
EP (1) EP2898099A4 (en)
JP (1) JP2015530094A (en)
KR (1) KR20150058465A (en)
CN (1) CN104812914B (en)
SG (1) SG11201502089QA (en)
WO (1) WO2014046623A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101843173B1 (en) * 2014-10-24 2018-03-29 씨비에스바이오사이언스 주식회사 Method of predicting sensitivity for vascular endothelial growth factor receptor inhibitor
KR102116178B1 (en) 2017-05-10 2020-05-27 서울대학교산학협력단 Biomarker for monitoring or detecting early onset of liver cancer from patient having high risk of liver cancer and its use
CN108048422A (en) * 2017-11-30 2018-05-18 天津市湖滨盘古基因科学发展有限公司 A kind of GTP enzymes, 7 mutain of IMAP family members and its application
CN110241198A (en) * 2019-05-30 2019-09-17 成都吉诺迈尔生物科技有限公司 A kind of genome recombination fingerprint and its identification method characterizing hHRD HR defective
CN111610262A (en) * 2020-05-19 2020-09-01 上海鹿明生物科技有限公司 Metabolism marker for diagnosing liver and gall diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003214604A1 (en) * 2002-03-21 2003-10-08 Hadasit Medical Research Services And Development Ltd. Peripheral blood cell markers useful for diagnosing multiple sclerosis and methods and kits utilizing same
EP1682904A2 (en) * 2003-11-04 2006-07-26 Roche Diagnostics GmbH Method for distinguishing who classified aml subtypes
EP1830289A1 (en) * 2005-11-30 2007-09-05 Institut National De La Sante Et De La Recherche Medicale (Inserm) Methods for hepatocellular carninoma classification and prognosis
WO2008138578A2 (en) * 2007-05-11 2008-11-20 Medical Prognosis Institute Methods, kits, and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy
WO2010054379A2 (en) * 2008-11-10 2010-05-14 The United States Of America, As Represensted By The Secretary, Department Of Health And Human Services Gene signature for predicting prognosis of patients with solid tumors

Also Published As

Publication number Publication date
KR20150058465A (en) 2015-05-28
CN104812914B (en) 2020-07-24
US20150232943A1 (en) 2015-08-20
CN104812914A (en) 2015-07-29
EP2898099A4 (en) 2016-05-25
JP2015530094A (en) 2015-10-15
EP2898099A1 (en) 2015-07-29
WO2014046623A1 (en) 2014-03-27

Similar Documents

Publication Publication Date Title
HK1213947A1 (en) Compositions and methods for diagnosing thyroid tumors
HK1205964A1 (en) Kit and devices for organ perfusion
PL3363901T3 (en) Compositions and methods for accurately identifying mutations
EP2751748A4 (en) Methods and arrangements for identifying objects
IL223147B (en) Means and methods for diagnosing pancreatic cancer in a subject
HK1210522A1 (en) Bladder cancer detection composition kit, and associated methods
ZA201805056B (en) Compositions and methods for identifying a risk of cancer in a subject
PL2880180T3 (en) Methods and kits for screening patients with a cancer
HK1211345A1 (en) Methods of prognosis and diagnosis of cancer
HK1209832A1 (en) Method and kit for determination of free copper in serum
IL232466A0 (en) Compositions and methods for prostate cancer analysis
SG11201502089QA (en) Methods of diagnosing liver cancer in a subject and a kit for diagnosing liver cancer
EP2879715A4 (en) Method and kit for bowel preparation
EP2880443A4 (en) Methods and compositions for diagnosis and prognosis in breast cancer
PL2517687T3 (en) Method and kit for depilation
PL2561856T3 (en) Method and kit for depilation
PL2559421T3 (en) Method and kit for depilation
EP2740801A4 (en) Sphingomyelin measurement method and measurement kit
EP2569441A4 (en) Kit and method
SG11201501838RA (en) Completion assembly and methods for use thereof
EP2732287A4 (en) Methods of diagnosing cancer
EP2893042A4 (en) Diagnostic testing in dementia and methods related thereto
GB201201129D0 (en) Kit and method
GB201101021D0 (en) Kit and method
GB201120454D0 (en) Kit and uses thereof